Nobias Therapeutics Alternatives & Competitors

12 companies similar to Nobias Therapeutics — Clinical-stage company developing novel small molecule therapeutics for rare dis...

X4 Pharmaceuticals

Enabling a better future for people with rare immune disorders

137 Post-IPO Debt $520.31M

Boston, United States

Biotechnology Health Care +2

Emalex Biosciences

Improving people's lives impacted by central nervous system disorders through meaningful s...

54 Series D $300.00M

Chicago, United States

Biopharma Biotechnology +3

Cancer Prevention Pharmaceuticals, Inc

Developing therapeutics to reduce the risk and recurrence of cancer and other diseases.

6 Debt Financing

Biotechnology Health Care +1

Xosomix

Next generation therapeutics based on exosomes

San Diego, United States

Health Care Health and Wellness

Track all Nobias Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Marinus Pharma

Dedicated to the development of innovative therapeutics to treat seizure disorders

111 Post-IPO Equity

United States

Biopharma Biotechnology +3

Balance Therapeutics Inc.

Harnessing neuroscience to improve quality of life

5 Series B $21.18M

Developer Tools Health Care +2

Selective Mutism Anxiety & Related Disorders Treatment Center (SMart Center)

Over 6,000 individuals treated worldwide using Dr. Elisa Shipon-Blum's S-CAT® approach

Jenkintown, United States

Health Care Health and Wellness

ProJenX

ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...

9 Series A $21.00M

New York, United States

Biopharma Biotechnology +2

Biosight Ltd.

Developing innovative pharmaceuticals for hematological malignancies and disorders

3 Series C $59.00M

Lod, Israel

Biotechnology Health Care +2

Viking Therapeutics, Inc.

59 Post-IPO Equity $1.06B

San Diego, United States

Health Care Health and Wellness

Petra Pharma

Pioneering novel therapies to address cancer and metabolic disorders by targeting essentia...

Debt Financing $75.55M

Biotechnology Health Care +2

Ophidion

Advancing brain-targeted therapies with precision and innovation for neurodegenerative and...

Convertible Note $1.70M

Biotechnology Health Care +1

About Nobias Therapeutics

Nobias Therapeutics is an AI-first therapeutics company founded in 2020, with a focus on the health care sector. The company is currently engaged in a phase 2 clinical trial aimed at addressing symptoms of anxiety, inattention, and autism in children with 22q11 deletion syndrome. Nobias has recently secured a significa...

Taxonomy

AI-first, Therapeutics, Clinical Trial, Anxiety Treatment, Attention Treatment, Autism Treatment, Pediatric Therapies, 22q11 Deletion Syndrome, Phase 2, Drug Development, Neurobehavioral Disorders

Frequently Asked Questions

Companies similar to Nobias Therapeutics include X4 Pharmaceuticals, Emalex Biosciences, Cancer Prevention Pharmaceuticals, Inc, Xosomix, Marinus Pharma. They work in Health Care and Health and Wellness and share Nobias Therapeutics's focus on drug development and therapeutics.

Bounce Watch lists 12 companies that share Nobias Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Nobias Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Nobias Therapeutics Profile X4 Pharmaceuticals Alternatives Emalex Biosciences Alternatives Xosomix Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Nobias Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.